Home › Companies › Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc. proxy voting records

How asset managers voted at Soleno Therapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number834203
• SEC CIK1484565

Recent shareholder votes

• June 5, 2025 annual meeting (2024-2025 proxy season): 3 items in Soleno Therapeutics, Inc.'s official results (Form 8-K, filed June 6, 2025); lowest support 70% of votes cast (Elect Director: William Harris). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Explore Soleno Therapeutics, Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.